Related Experiment Video
Updated: Jan 22, 2026

Alveolar Macrophage Phagocytosis and Bacteria Clearance in Mice
Published on: March 2, 2019
Plasmin modulates neutrophilic inflammation and alveolar macrophage function, protecting mice from pneumococcal
Camila Cardoso1,2, Antônio Felipe Silva Carvalho1, Edvaldo S Lara1
1Signaling in Inflammation Laboratory, Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Abstract:
Accumulating evidence supports the proresolving actions of the plasminogen/plasmin (Plg/Pla) system during inflammation, beyond its classical role in fibrin degradation. Here, we investigated the role of Plg/Pla on key features of inflammation resolution in a murine model of severe pneumococcal pneumonia. High levels of Plg were observed in the airways after infection, accompanied by increased levels of Plg activator inhibitor-1, neutrophil elastase, and Plg degradation fragments as inflammation progressed. Pla treatment of mice infected with Streptococcus pneumoniae decreased neutrophilic infiltration in airways and lungs, accompanied by lower concentrations of the neutrophil chemoattractive chemokines CXCL1 and CXCL2 and the proinflammatory cytokines tumor necrosis factor, interleukin-6 (IL-6), and IL-1β. Pla treatment also enhanced neutrophil apoptosis and efferocytosis and slightly reduced bacterial loads in bronchoalveolar lavage. In addition, Pla decreased damage and fibrin deposition in the lungs, improving pneumonia-driven pulmonary mechanical dysfunction and rescuing mice from lethality. Pla-induced resolution of S pneumoniae-evoked inflammation was associated with neutrophil apoptosis, as the caspase-3-specific inhibitor Z-DEVD-FMK blocked Pla-protective actions. In addition to the effects on neutrophils, intranasal instillation of Pla in naive mice increased the number of alveolar macrophages and guided them toward a regulatory phenotype marked by enhanced efferocytosis of apoptotic neutrophils and increased bacterial phagocytosis, ultimately promoting host protection against pneumococcus-induced inflammation and tissue damage. In sum, our findings demonstrate that Pla modulates the lung inflammatory milieu and promotes key proresolving events, namely neutrophil apoptosis and expansion of alveolar macrophage with enhanced efferocytosis and phagocytic abilities, resulting in improved lung function and survival in pneumococcal pneumonia.
Insights
Plasmin (Pla) treatment resolves severe pneumococcal pneumonia by enhancing neutrophil apoptosis and macrophage efferocytosis. This reduces lung inflammation, improves lung function, and increases survival in a murine model.
Area of Science:
- Immunology
- Pulmonology
- Biochemistry
Background:
- The Plasminogen/Plasmin (Plg/Pla) system has emerging roles in inflammation resolution beyond fibrinolysis.
- Pneumococcal pneumonia triggers significant lung inflammation and injury.
Purpose of the Study:
- To investigate the role of the Plg/Pla system in resolving inflammation during pneumococcal pneumonia in mice.
- To elucidate the mechanisms by which Plg/Pla influences immune cell function and lung pathology.
Main Methods:
- Murine model of Streptococcus pneumoniae (Sp) pneumonia.
- Treatment with Plasmin (Pla).
- Analysis of inflammatory markers, immune cell apoptosis, efferocytosis, bacterial load, lung mechanics, and survival.
Main Results:
- Pla treatment reduced neutrophilic infiltration, pro-inflammatory cytokines (TNF, IL-6, IL-1β), and chemokines (CXCL1, CXCL2).
- Pla enhanced neutrophil apoptosis and efferocytosis, decreased lung damage and fibrin deposition, and improved pulmonary mechanics.
- Pla promoted regulatory alveolar macrophages with enhanced efferocytosis and phagocytosis, improving host protection and survival.
Conclusions:
- Plasmin actively resolves pneumococcal pneumonia by promoting neutrophil apoptosis and modulating macrophage phenotype.
- Pla treatment improves lung function and survival in severe pneumonia through pro-resolving immune mechanisms.
More Related Videos
Related Concept Videos
Inflammation
Alveoli and Alveolar Ducts
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Zones of Protection
Protective zones are defined by closed dashed lines, containing one or more components. A key characteristic of these zones is the strategic placement of...
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...

